Comprehensive analysis of the TGF-β signaling pathway: molecular mechanisms, disease drivers, and frontiers in clinical translation - Scorecard - MDSpire

Comprehensive analysis of the TGF-β signaling pathway: molecular mechanisms, disease drivers, and frontiers in clinical translation

  • By

  • Yiting Zhang

  • Haixia Tang

  • Ze Zhou

  • Jiabao Liao

  • Xiaoyu Zhou

  • Xin Chu

  • Mengqiu Shao

  • Caiyan Zhang

  • Lijuan Jiang

  • June 4, 2026

  • 0 min

Share

Clinical Scorecard: In-depth Exploration of TGF-β Signaling Pathway: Molecular Mechanisms, Disease Implications, and Advances in Clinical Application

At a Glance

CategoryDetail
ConditionTGF-β signaling pathway dysregulation
Key MechanismsSmad-dependent and Smad-independent pathways regulating immune cell differentiation and function
Target PopulationPatients with immune-related diseases, fibrosis, and tumors
Care SettingClinical and research settings focusing on immune modulation and therapeutic interventions

Key Highlights

  • TGF-β maintains immune tolerance and regulates T-cell fate determination.
  • Aberrant TGF-β signaling drives fibrosis and tumor immune evasion.
  • Innovative technologies have revealed dynamic characteristics of TGF-β signaling.
  • Therapeutic strategies targeting TGF-β show potential but face challenges.
  • TGF-β's role is context-dependent, varying by disease stage and microenvironment.

Guideline-Based Recommendations

Diagnosis

  • Assess TGF-β signaling pathway activity in immune-related diseases.

Management

  • Consider therapeutic strategies targeting TGF-β, including receptor kinase inhibitors and bispecific antibodies.

Monitoring & Follow-up

  • Monitor for toxicity and side effects associated with TGF-β-targeted therapies.

Risks

  • Potential for adverse effects due to TGF-β's role in immune modulation and fibrosis.

Patient & Prescribing Data

Individuals with conditions related to TGF-β dysregulation, such as fibrosis and cancer.

Targeted therapies may require patient stratification based on disease stage and microenvironment.

Clinical Best Practices

  • Utilize single-cell omics and spatial transcriptomics for understanding TGF-β signaling.
  • Implement combination therapies to enhance efficacy and reduce side effects.
  • Focus on precise nanodelivery systems for targeted TGF-β interventions.

Related Resources & Content

Original Source(s)

Related Content